Treatment Plan: 1.4 kg Neonate, HBsAg-Positive Mother, Suspected Down Syndrome

1. Very Low Birth Weight (VLBW) — 1.4 kg (weight <1500 g by definition)
2. Vertical Hepatitis B exposure — mother is HBsAg positive
3. Suspected Trisomy 21 (Down syndrome) — requires urgent workup and monitoring

I. VLBW Neonatal Stabilization (Immediate — Delivery Room & NICU)

A. Thermal Management

• Immediately place in a preheated incubator or radiant warmer; target skin temperature 36.5–37.5°C
• Use polyethylene wrap at delivery to minimize insensible heat/water loss
• VLBW neonates have very high total body water (up to 90% body weight) and are extremely vulnerable to hypothermia and dehydration

B. Respiratory Support

• Assess with APGAR score at 1 and 5 minutes
• Monitor for respiratory distress syndrome (RDS) — the single biggest cause of morbidity in premature neonates
• Initiate CPAP early if there is grunting, nasal flaring, or retractions
• Prepare for exogenous surfactant therapy if FiO₂ requirements rise (>0.30 on CPAP) or if CXR confirms RDS
• Target oxygen saturation 91–95% (avoid hyperoxia — risk of retinopathy of prematurity)
• Avoid unnecessary intubation; use non-invasive ventilation preferentially

C. Cardiovascular / Hemodynamic

• Continuous cardiorespiratory monitoring
• Blood pressure monitoring — Mean Arterial Pressure (MAP) should be ≥ gestational age in weeks (as a rough guide)
• Watch for patent ductus arteriosus (PDA), extremely common in VLBW infants; VLBW is a specific risk factor for hemodynamically significant PDA
• Note: Down syndrome carries ~50% risk of congenital heart disease — echocardiogram is mandatory (see below)

D. Fluid and Nutrition

• Start IV 10% dextrose (D10W) at 60–80 mL/kg/day on Day 1; adjust based on glucose monitoring
• VLBW/preterm neonates have higher glucose needs and are prone to hypoglycemia — check blood glucose within 30 minutes of birth and every 1–3 hours initially; maintain ≥45–50 mg/dL
• Begin parenteral nutrition (PN) early — amino acids from Day 1, lipids from Day 2 if tolerating
• Advance enteral feeds (breast milk preferred) as soon as hemodynamically stable; mothers with hepatitis B can breastfeed safely once prophylaxis is administered to the infant
• Electrolyte monitoring: Na, K, Ca — VLBW infants are prone to electrolyte disturbances due to high insensible losses

E. Infection Prophylaxis/Sepsis

• VLBW preterm neonates are at high risk for early-onset neonatal sepsis
• Obtain blood culture; start empirical ampicillin + gentamicin if there are any signs of sepsis or chorioamnionitis was present
• Standard precautions if mother had clinical hepatitis; coordinate with infection control
• Rosen's Emergency Medicine: "An acceptable regimen includes dual therapy with ampicillin and gentamicin" for preterm neonates with suspected infection

F. Hematologic

• Monitor CBC — watch for anemia, thrombocytopenia (early sign of sepsis)
• Vitamin K 0.5 mg IM at birth (VLBW dose)
• Coagulation parameters differ from term infants — monitor PT/aPTT

G. Other Monitoring

• Screen for hyperbilirubinemia (phototherapy thresholds are lower in preterm infants)
• Ophthalmology follow-up at 31 weeks PMA (or 4 weeks after birth, whichever is later) for retinopathy of prematurity (ROP) screening
• Cranial ultrasound to screen for intraventricular hemorrhage (IVH) — VLBW infants have significantly increased risk

II. Hepatitis B Prophylaxis (Birth to <12 Hours — Critical Window)

Fig 3.5 — Red Book 2021, AAP Committee on Infectious Diseases

Action Steps:

• HBIG effectiveness diminishes with delay; the window is likely ≤7 days — must act within 12 hours
• Without prophylaxis, vertical transmission occurs in 70–90% of HBsAg+/HBeAg+ mothers; prophylaxis reduces this to <10%
• Confirm maternal HBV DNA and HBeAg status — if HBeAg positive or high viral load, maternal antiviral treatment may be indicated (tenofovir) — this does not change the infant's immediate management
• If maternal HBV status is confirmed HBsAg-positive, vaccinate as above regardless of birth weight — Red Book 2021, AAP, p. 636–639

III. Down Syndrome (Trisomy 21) — Neonatal Workup and Management

• Generalized hypotonia (most prominent early sign)
• Oblique (upslanting) palpebral fissures
• Flat facial profile / flat nasal bridge
• Abundant neck skin / short neck
• Single palmar (simian) crease
• Fifth finger clinodactyly
• Short broad hands

A. Confirm Diagnosis

• Chromosomal karyotype (peripheral blood) — order immediately; confirms trisomy 21 vs. translocation vs. mosaic
• Microarray-comparative genomic hybridization (CGH) can also be used

B. Cardiac Workup — Urgent

• Echocardiogram within the first few days of life
• ~50% of Down syndrome infants have congenital heart disease (CHD); most common lesion: atrioventricular septal defect (AVSD/endocardial cushion defect), also VSD, ASD, PDA, TOF
• Cardiology consultation immediately — significant CHD may require surgical planning
• Swanson's Family Medicine Review: "Any newborn identified with the features of trisomy 21 should have a screening echocardiogram"

C. Other Structural Anomalies

• Abdominal X-ray / clinical evaluation for duodenal atresia (double-bubble sign) — significantly more common in Down syndrome; presents with bilious vomiting
• Screen for tracheoesophageal fistula (TE fistula) and esophageal atresia
• Renal ultrasound (renal anomalies possible)

D. Endocrine

• Congenital hypothyroidism screening (included in standard newborn metabolic screening panel) — Down syndrome has elevated incidence; confirm TSH/T4 on newborn screen
• If screen is abnormal, start levothyroxine promptly

E. Hematologic

• Down syndrome newborns have an increased incidence of transient abnormal myelopoiesis (TAM) — a transient leukemoid reaction that can evolve into leukemia in ~20%
• Order CBC with differential and blood smear — look for blast cells
• Hematology consultation if CBC shows circulating blasts
• Monitor for polycythemia (hematocrit >65%), particularly important given preterm status

F. Neurodevelopment / Airway

• Hypotonia impacts feeding ability — early speech therapy/occupational therapy consultation for feeding assessment
• Atlantoaxial instability screening is not needed in the immediate neonatal period but is required before activities causing cervical flexion (typically at ~3–5 years)
• Early intervention programs should be initiated as early as possible

G. Ophthalmologic

• Neonatal eye exam; cataracts can occur in Down syndrome

H. Audiology

• Hearing screen (standard newborn hearing screening — particularly important as hearing loss is common in Down syndrome)

I. Genetic Counseling

• Offer to parents once stable — discuss recurrence risk (depends on karyotype type: free trisomy ~1%, translocation higher)

IV. Priority Summary: Immediate First 12 Hours

Sources

• Red Book 2021 — AAP Committee on Infectious Diseases, Hepatitis B, pp. 636–639
• The Harriet Lane Handbook, 23rd ed. — Newborn Assessment, VLBW definitions
• Rosen's Emergency Medicine — Preterm neonate empirical antibiotic therapy
• Thompson & Thompson Genetics and Genomics in Medicine, 9th ed. — Down Syndrome clinical features
• Swanson's Family Medicine Review — Echocardiogram indication in Down syndrome
• Miller's Anesthesia, 10th ed. — Neonatal oxygen saturation targets, NICU thermoregulation
• Barash Clinical Anesthesia, 9th ed. — Fluid/glucose management in VLBW neonates

Note: This plan should be implemented by a neonatologist in a Level III/IV NICU. The combination of VLBW, suspected Down syndrome (with potential congenital heart disease), and HBV exposure makes this a high-complexity case requiring multidisciplinary input from neonatology, cardiology, hematology, genetics, and infectious disease.The treatment plan above addresses all three concurrent clinical problems comprehensively. A few key points to emphasize: